Parmax Pharma Limited (BOM:540359)
120.10
+2.35 (2.00%)
At close: Aug 17, 2026
211.62% (1Y)
| Market Cap | 449.33M +211.6% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 3.74M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,490 |
| Open | 120.10 |
| Previous Close | 117.75 |
| Day's Range | 120.10 - 120.10 |
| 52-Week Range | 22.60 - 120.10 |
| Beta | 0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |